Market Overview:
The global pet veterinary drug market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for pet health care and rising awareness about animal health among consumers. In addition, the increasing prevalence of zoonotic diseases is also contributing to the growth of this market. The global pet veterinary drug market can be segmented on the basis of type into anti-infectives, anti-inflammatory agents, parasiticides, analgesics, sedatives and others. The analgesics segment is expected to grow at a CAGR of 6% during the forecast period from 2018 to 2030. This growth can be attributed to an increase in cases of pain in pets due to various reasons such as old age or injuries sustained while playing or running around outdoors. On the basis of application, the global pet veterinary drug market can be divided into veterinary hospitals, clinics and pharmacies/drug stores. The veterinary hospitals segment is projected grow at a CAGR 7% duringthe forecast period from 2018to2030 owingto an increasein adoptionof pets by people across different age groupsand rising disposable income levels in emerging economies such as China and India .
Product Definition:
A pet veterinary drug is a medication that is prescribed by a veterinarian to treat an illness or injury in a pet. These drugs can be used to treat conditions such as arthritis, cancer, and heart disease in pets. The use of pet veterinary drugs can help improve the quality of life for pets and extend their lifespan.
Anti-Infectives:
Anti-infectives is a group of drugs used to treat bacterial infections. Anti-infective drugs are primarily used for the treatment and prevention of diseases that are caused by bacteria. Some viruses also cause disease in animals, but they can be treated using antiviral agents as well. Bacterial infection in pets leads to various clinical signs such as high temperature, lameness, etc., if not treated at the right time then it may lead to death of animal.
Anti-Inflammatory:
An inflammatory disease is when the body's immune system reacts to an invader such as a bacteria, virus, or parasite. The normal functioning of the body's immune system is normally kept in check by "inflammatory response" cells and molecules. However, in some cases these response mechanisms go awry and cause inflammation instead of keeping infection at bay. Inflammation can be acute (lasting a short time) or chronic (long term).
Application Insights:
The veterinary hospitals segment dominated the global pet veterinary drug market in 2017. This is attributed to factors such as presence of a large number of veterinarians, availability of advanced healthcare facilities and infrastructure, and increasing focus on animal health by the general public. The Veterinary Hospital category has been further categorized into Large & Medium-sized Animal Hospitals (Vets) and Small Animal Hospitals (Drs). Large & medium-sized animal hospitals are more expensive than small animal clinics but offer a higher standard of care for animals with complex medical conditions or injuries. These types Vet Centers that provide high quality services at affordable prices to both human patients as well as their pets worldwide through online vet portals or mobile apps.
Regional Analysis:
North America dominated the global pet veterinary drug market in 2017. The growth is attributed to rising demand for pet insurance, increasing awareness about animal health and well-being, and high disposable income of consumers. According to an article published in the International Journal of Environmental Research & Public Health, U.S. is among the top three countries with respect to spending on pets (after China and Japan). In 2016, around USD X billion were spent on pets in this country; approximately one-third was spent on veterinary care alone.
Growth Factors:
- Increasing pet ownership: The global pet population is expected to grow at a CAGR of 3.8% from 2016 to 2021, reaching 862 million by 2021. This growth in the pet population will lead to an increase in demand for veterinary drugs and services.
- Rising awareness about animal health and preventive care: There is a growing awareness among pet owners about the importance of preventive care for their pets, which is driving demand for veterinary drugs and services.
- Growing demand for specialty veterinary drugs: A growing number of people are opting for specialty breeds of animals that require specialized veterinary drugs and treatments. This is leading to an increase in demand for specialty veterinary drugs worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
Pet Veterinary Drug Market Research Report
By Type
Anti-Infectives, Anti-Inflammatory, Parasiticides, Analgesics, Sedatives, Others
By Application
Veterinary Hospitals, Veterinary Clinics, Drug Stores
By Companies
Boehringer Ingelheim International GmbH, Zoetis Animal Healthcare, Bayer AG, Merck Animal Health, Elanco Animal Health Inc., Virbac Group, Ceva, Dechra Pharmaceuticals Plc, Vetoquinol, Orion Corporation, Boehringer Ingelheim International GmbH
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
207
Number of Tables & Figures
145
Customization Available
Yes, the report can be customized as per your need.
Global Pet Veterinary Drug Market Report Segments:
The global Pet Veterinary Drug market is segmented on the basis of:
Types
Anti-Infectives, Anti-Inflammatory, Parasiticides, Analgesics, Sedatives, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Veterinary Hospitals, Veterinary Clinics, Drug Stores
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Boehringer Ingelheim International GmbH
- Zoetis Animal Healthcare
- Bayer AG
- Merck Animal Health
- Elanco Animal Health Inc.
- Virbac Group
- Ceva
- Dechra Pharmaceuticals Plc
- Vetoquinol
- Orion Corporation
- Boehringer Ingelheim International GmbH
Highlights of The Pet Veterinary Drug Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Anti-Infectives
- Anti-Inflammatory
- Parasiticides
- Analgesics
- Sedatives
- Others
- By Application:
- Veterinary Hospitals
- Veterinary Clinics
- Drug Stores
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pet Veterinary Drug Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A pet veterinary drug is a medication that is specifically designed for use in animals. These medications are often prescribed by veterinarians to treat specific medical conditions in pets.
Some of the major players in the pet veterinary drug market are Boehringer Ingelheim International GmbH, Zoetis Animal Healthcare, Bayer AG, Merck Animal Health, Elanco Animal Health Inc., Virbac Group, Ceva, Dechra Pharmaceuticals Plc, Vetoquinol, Orion Corporation, Boehringer Ingelheim International GmbH.
The pet veterinary drug market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Pet Veterinary Drug Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Pet Veterinary Drug Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Pet Veterinary Drug Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Pet Veterinary Drug Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Pet Veterinary Drug Market Size & Forecast, 2018-2028
4.5.1 Pet Veterinary Drug Market Size and Y-o-Y Growth
4.5.2 Pet Veterinary Drug Market Absolute $ Opportunity
Chapter 5 Global Pet Veterinary Drug Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Pet Veterinary Drug Market Size Forecast by Type
5.2.1 Anti-Infectives
5.2.2 Anti-Inflammatory
5.2.3 Parasiticides
5.2.4 Analgesics
5.2.5 Sedatives
5.2.6 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Pet Veterinary Drug Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Pet Veterinary Drug Market Size Forecast by Applications
6.2.1 Veterinary Hospitals
6.2.2 Veterinary Clinics
6.2.3 Drug Stores
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Pet Veterinary Drug Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Pet Veterinary Drug Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Pet Veterinary Drug Analysis and Forecast
9.1 Introduction
9.2 North America Pet Veterinary Drug Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Pet Veterinary Drug Market Size Forecast by Type
9.6.1 Anti-Infectives
9.6.2 Anti-Inflammatory
9.6.3 Parasiticides
9.6.4 Analgesics
9.6.5 Sedatives
9.6.6 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Pet Veterinary Drug Market Size Forecast by Applications
9.10.1 Veterinary Hospitals
9.10.2 Veterinary Clinics
9.10.3 Drug Stores
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Pet Veterinary Drug Analysis and Forecast
10.1 Introduction
10.2 Europe Pet Veterinary Drug Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Pet Veterinary Drug Market Size Forecast by Type
10.6.1 Anti-Infectives
10.6.2 Anti-Inflammatory
10.6.3 Parasiticides
10.6.4 Analgesics
10.6.5 Sedatives
10.6.6 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Pet Veterinary Drug Market Size Forecast by Applications
10.10.1 Veterinary Hospitals
10.10.2 Veterinary Clinics
10.10.3 Drug Stores
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Pet Veterinary Drug Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Pet Veterinary Drug Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Pet Veterinary Drug Market Size Forecast by Type
11.6.1 Anti-Infectives
11.6.2 Anti-Inflammatory
11.6.3 Parasiticides
11.6.4 Analgesics
11.6.5 Sedatives
11.6.6 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Pet Veterinary Drug Market Size Forecast by Applications
11.10.1 Veterinary Hospitals
11.10.2 Veterinary Clinics
11.10.3 Drug Stores
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Pet Veterinary Drug Analysis and Forecast
12.1 Introduction
12.2 Latin America Pet Veterinary Drug Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Pet Veterinary Drug Market Size Forecast by Type
12.6.1 Anti-Infectives
12.6.2 Anti-Inflammatory
12.6.3 Parasiticides
12.6.4 Analgesics
12.6.5 Sedatives
12.6.6 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Pet Veterinary Drug Market Size Forecast by Applications
12.10.1 Veterinary Hospitals
12.10.2 Veterinary Clinics
12.10.3 Drug Stores
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Pet Veterinary Drug Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Pet Veterinary Drug Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Pet Veterinary Drug Market Size Forecast by Type
13.6.1 Anti-Infectives
13.6.2 Anti-Inflammatory
13.6.3 Parasiticides
13.6.4 Analgesics
13.6.5 Sedatives
13.6.6 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Pet Veterinary Drug Market Size Forecast by Applications
13.10.1 Veterinary Hospitals
13.10.2 Veterinary Clinics
13.10.3 Drug Stores
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Pet Veterinary Drug Market: Competitive Dashboard
14.2 Global Pet Veterinary Drug Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Boehringer Ingelheim International GmbH
14.3.2 Zoetis Animal Healthcare
14.3.3 Bayer AG
14.3.4 Merck Animal Health
14.3.5 Elanco Animal Health Inc.
14.3.6 Virbac Group
14.3.7 Ceva
14.3.8 Dechra Pharmaceuticals Plc
14.3.9 Vetoquinol
14.3.10 Orion Corporation
14.3.11 Boehringer Ingelheim International GmbH
